Evidence map›Paper›PMID 42471556›Full record

SynthesisBMC infectious diseases2026

Correlates of hepatitis B virus awareness and disease specific knowledge in Uganda: a meta-analysis and meta-regression of studies published between 2018 and 2025.

Hussein Mukasa Kafeero, Hakim Sendagire, Dorothy Ndagire, Abdul Walusansa, Ali Kudamba, Fahad Muwanda, Mariam Namusoke, Ponsiano Ocama

Abstract readMeta-Analysis
In one paragraph

Synthesis in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hussein Mukasa KafeeroDepartment of Medical Microbiology, Faculty of Health Sciences, Islamic University in Uganda, P.O Box 7689, Kampala, Uganda. husseinmukasakafeero@gmail.com.ORCID https://orcid.org/0000-0002-9418-2831
Hakim SendagireDepartment of Medical Microbiology, College of Health Sciences, Makerere University, P.O Box 7062, Kampala, Uganda.
Dorothy NdagireDepartment of Plant Sciences, Microbiology and Biotechnology, College of Natural Sciences, Makerere University, P.O Box 7062, Kampala, Uganda.
Abdul WalusansaDepartment of Medical Microbiology, Faculty of Health Sciences, Islamic University in Uganda, P.O Box 7689, Kampala, Uganda.
Ali KudambaDepartment of Physiology, Habib Medical School, Faculty of Health Sciences, Islamic University in Uganda, P.O Box 7689, Kampala, Uganda.
Fahad MuwandaDepartment of Medical Laboratory Sciences, Faculty of Health Sciences, Islamic University in Uganda, P.O Box 7689, Kampala, Uganda.
Mariam NamusokeDepartment of Medical Biochemistry, Faculty of Health Sciences, Islamic University in Uganda, P.O Box 7689, Kampala, Uganda.
Ponsiano OcamaDepartment of medicine, College of Health Sciences, Makerere University, P.O Box 7062, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis B virus (HBV) remains a major public health challenge in Uganda, where prevalence varies by region and population group despite national vaccination and screening initiatives. Understanding awareness and knowledge levels is essential for guiding HBV prevention and control strategies. This study synthesized available evidence on the correlates of HBV awareness and disease specific knowledge among different Ugandan populations.

methodsWe systematically searched PubMed, African Journals Online (AJOL), and Google Scholar for cross-sectional studies reporting on HBV awareness or disease-specific knowledge in Uganda, published between January 2018 and December 2025. Study selection, data extraction, and quality appraisal were conducted independently by two reviewers using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for Analytical Cross-Sectional Studies. Eighteen studies meeting the eligibility criteria were included in the final synthesis. Pooled estimates of HBV awareness and correlates of disease-specific knowledge were computed using a random-effects model in MedCalc software (version 10.10), with heterogeneity quantified using the I² statistic. Sources of heterogeneity were explored through subgroup analysis and sensitivity analysis. Meta-regression was performed to examine trends in HBV awareness by region, year of publication, and study population. Publication bias was assessed using Begg's and Egger's tests. Statistical significance was set at p < 0.05, and all estimates are reported with 95% confidence intervals.

resultsEighteen studies met the inclusion criteria. The pooled prevalence of HBV awareness was 75.3% (95% CI: 61.5%-86.9%), with substantial heterogeneity observed across regions and population groups (I²=99.24%). Subgroup analysis revealed that awareness was significantly higher in Central Uganda compared to the northern, eastern, and western regions (p < 0.05), and among healthcare workers compared to the general population and antenatal care attendees (p < 0.05). Knowledge of specific HBV domains varied considerably: awareness of the causative agent, screening services, and vaccination availability was significantly higher among knowledgeable participants compared to those with no prior HBV knowledge (p < 0.05), whereas awareness of post-exposure prophylaxis and completion of the full HBV vaccination schedule remained low compared to those who had received at least partial vaccination (p < 0.05). Awareness of key transmission routes including sexual contact, needle sharing, and mother-to-child transmission was moderate, though knowledge of transmission through infected body fluids remained poor. Participants who were of higher education level were more likely to take up vaccination compared to lower education level (p < 0.05), and participants with a positive attitude toward vaccine effectiveness were significantly more likely to be vaccinated compared to those with a negative attitude (p < 0.05). The meta-regression analysis further revealed a paradoxical overall decline in HBV awareness over the study period.

conclusionCritical gaps still persist in HBV awareness and key knowledge areas highlighting the need for alternative strategies tailored to the social dynamics of the current generation during the delivery of health messages. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Health Knowledge, Attitudes, PracticeHepatitis BHepatitis B virusCross-Sectional StudiesHepatitis B VaccinesHumansUgandaVaccinationHepatitis B VaccinesAwarenessHepatitis B virusKnowledgePost-exposure prophylaxisScreeningTransmission routesVaccination

Identifiers

PMID42471556
PMCPMC13670831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.